131 related articles for article (PubMed ID: 34051630)
1. From medium to endoplasmic reticulum: Tracing anticancer phenolato titanium(IV) complex by
Nahari G; Hoffman RE; Tshuva EY
J Inorg Biochem; 2021 Aug; 221():111492. PubMed ID: 34051630
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of asymmetrical diaminobis(alkoxo)-bisphenol compounds and their C
Nahari G; Tshuva EY
Dalton Trans; 2021 May; 50(19):6423-6426. PubMed ID: 33949509
[TBL] [Abstract][Full Text] [Related]
3. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
5. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
[TBL] [Abstract][Full Text] [Related]
6. Phenolato Ti(IV) hexacoordinate complexes for anticancer chemotherapy: enhancement of solubility, hydrolytic stability, and cytotoxicity.
Taha M; Tshuva EY
Dalton Trans; 2023 Jun; 52(22):7664-7672. PubMed ID: 37199994
[TBL] [Abstract][Full Text] [Related]
7. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
Manna CM; Tshuva EY
Dalton Trans; 2010 Feb; 39(5):1182-4. PubMed ID: 20104339
[TBL] [Abstract][Full Text] [Related]
8. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
Meker S; Manna CM; Peri D; Tshuva EY
Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
[TBL] [Abstract][Full Text] [Related]
9. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro antitumor evaluation and structure activity relationship of heptacoordinated amino-bis(Phenolato) Ti(IV) complexes stabilized by 2,6-dipicolinic acid.
Li S; Zhang X; Zhao T; Liu N; Zhang Y; Wang P; Yang Z; Huhn T
J Biol Inorg Chem; 2024 Apr; 29(3):315-330. PubMed ID: 38722397
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological Reactivity.
Miller M; Tshuva EY
Sci Rep; 2018 Jun; 8(1):9705. PubMed ID: 29946136
[TBL] [Abstract][Full Text] [Related]
12. Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands.
Shavit M; Peri D; Manna CM; Alexander JS; Tshuva EY
J Am Chem Soc; 2007 Oct; 129(40):12098-9. PubMed ID: 17877357
[No Abstract] [Full Text] [Related]
13. Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.
Meker S; Margulis-Goshen K; Weiss E; Braitbard O; Hochman J; Magdassi S; Tshuva EY
ChemMedChem; 2014 Jun; 9(6):1294-8. PubMed ID: 24677761
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
15. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
16. Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug.
Miller M; Mellul A; Braun M; Sherill-Rofe D; Cohen E; Shpilt Z; Unterman I; Braitbard O; Hochman J; Tshuva EY; Tabach Y
iScience; 2020 Jul; 23(7):101262. PubMed ID: 32585595
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD
Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630
[TBL] [Abstract][Full Text] [Related]
18. High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.
Meker S; Margulis-Goshen K; Weiss E; Magdassi S; Tshuva EY
Angew Chem Int Ed Engl; 2012 Oct; 51(42):10515-7. PubMed ID: 22961758
[TBL] [Abstract][Full Text] [Related]
19. Binding of the anticancer Ti(IV) complex phenolaTi to serum proteins: Thermodynamic and kinetic aspects.
Shpilt Z; Tshuva EY
J Inorg Biochem; 2022 Jul; 232():111817. PubMed ID: 35421765
[TBL] [Abstract][Full Text] [Related]
20. A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand.
Schur J; Manna CM; Deally A; Köster RW; Tacke M; Tshuva EY; Ott I
Chem Commun (Camb); 2013 May; 49(42):4785-7. PubMed ID: 23598498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
